Eric Jeffrey Topol
Topol, Eric J., 1954-
Topol, Eric J., 1954-...., cardiologue
![Sudoc [ABES], France](https://speed.lescigales.org/xypor/index.php?q=aHR0cHM6Ly92aWFmLm9yZy92aWFmL2ltYWdlcy9mbGFncy9TVURPQy5wbmc%3D "Sudoc [ABES], France")
Topol, Eric J.
Topol, Eric 1954-
VIAF ID: 109428739 (Personal)
Permalink: http://viaf.org/viaf/109428739
Preferred Forms
-
-
-
-
100 1 _ ‡a Topol, Eric J.
-
100 1 _ ‡a Topol, Eric J.
-
100 1 _ ‡a Topol, Eric J. ‡d (1954- ).
-
100 1 _ ‡a Topol, Eric J. ‡d 1954-
-
-
-
100 1 _ ‡a Topol, Eric J., ‡d 1954-
-
100 1 _ ‡a Topol, Eric J., ‡d 1954-
-
100 1 _ ‡a Topol, Eric J., ‡d 1954-
-
100 1 _ ‡a Topol, Eric J., ‡d 1954-
-
100 1 _ ‡a Topol, Eric J., ‡d 1954-
-
-
-
100 1 _ ‡a Topol, Eric J., ‡d 1954-
-
100 1 _ ‡a Topol, Eric J., ‡d 1954-
-
-
4xx's: Alternate Name Forms (24)
5xx's: Related Names (1)
Works
| Title | Sources |
|---|---|
| Acute coronary syndromes |
|
| Arterial remodeling : a critical factor in restenosis |
|
| Atherothrombosis and coronary artery disease |
|
| Cardiac drugs |
|
| Cardiología de bolsillo |
|
| The cardiology intensive board review question book |
|
| Cardiovascular thrombosis : thrombocardiology and thromboneurology |
|
| Cheongjingi ga sarajin ihu |
|
| Choroby serca : diagnostyka i terapia |
|
| The Creative destruction of medicine : how the digital revolution will create better health care |
|
| Deep medicine : how artificial intelligence can make healthcare human again |
|
| Deep Medicine : künstliche Intelligenz in der Medizin : wie KI das Gesundheitswesen menschlicher macht |
|
| Dip mediseun |
|
| Dipu medisun : Eai de omoiyari no aru iryo o. |
|
| Kardiologia interwencyjna. |
|
| Laat patiënten helpen! : een handboek over betrokkenheid van patiënten - hoe artsen, verpleegkundigen, patiënten en verzorgers kunnen samenwerken voor een betere zorg |
|
| Management of the patient in the coronary care unit |
|
| Medycyna głęboka : jak sztuczna inteligencja może przywrócić opiece zdrowotnej ludzką twarz |
|
| A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. |
|
| n87894830 |
|
| A novel molecular diagnostic marker for familial and early-onset coronary artery disease and myocardial infarction in the LRP8 gene. |
|
| Pan vascular medicine : integrated clinical management |
|
| Patient will see you now : the future of medicine is in your hands |
|
| Platelet glycoprotein IIb/IIIa inhibitors in cardiovascular disease |
|
| Podręcznik kardiologii Cleveland Clinic |
|
| A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease |
|
| The Reply |
|
| A robust hybrid between genetic algorithm and support vector machine for extracting an optimal feature gene subset |
|
| A symposium : anticoagulant therapy : new promises and challenges |
|
| Symposium on restenosis : from basic studies to clinical trials |
|
| Textbook of Cardiovascular Medicine |
|
| Textbook of interventional cardiology |
|
| Toward the quiescent coronary plaque |
|
| Towards a smart medical home |
|
| Transforming medicine via digital innovation |
|
| Treatment of recurrent ischemia after thrombolysis and successful reperfusion for acute myocardial infarction: effect on in-hospital mortality and left ventricular function |
|
| Troponin I in the Diagnosis of Postoperative Myocardial Infarction |
|
| Ultrathrombolysis |
|
| Unexpected mortality reduction with abciximab for in-stent restenosis. |
|
| Unpatients-why patients should own their medical data |
|
| Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials |
|
| Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries |
|
| Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. |
|
| Use of tissue plasminogen activator in the emergency department for acute myocardial infarction |
|
| Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage |
|
| Usefulness of coronary artery angioplasty strategies in acute myocardial infarction |
|
| Validation of the early open infarct vessel hypothesis |
|
| Value of intraoperative left ventricular microbubbles detected by transesophageal two-dimensional echocardiography in predicting neurologic outcome after cardiac operations |
|
| Variability of quantitative digital subtraction coronary angiography before and after percutaneous transluminal coronary angioplasty |
|
| A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction |
|
| Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications |
|
| Virtual care for improved global health |
|
| Warfarin alone or with aspirin was superior to aspirin alone after acute myocardial infarction but increased bleeding |
|
| Wearable sensor data and self-reported symptoms for COVID-19 detection |
|
| What accounts for the high cost of care? it's the people: a Q&A with Eric Topol, MD |
|
| When genomics goes digital |
|
| Which thrombolytic agent should one choose? |
|
| Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial |
|
| A Whole Blood Molecular Signature for Acute Myocardial Infarction |
|
| Whole-Genome Sequencing of a Healthy Aging Cohort |
|
| Эрик Топол: Беспроводное будущее медицины. |
|
| ভূমিকা |
|
| 딥메디슨 인공지능, 의료의 인간화를 꿈꾸다 |
|
| 에릭 토폴 : 무선 기술이 열어가는 의술의 미래 |
|
| 청진기가 사라진다 |
|
| ディープメディスン : AIで思いやりのある医療を! |
|
| 心血管インターベンション |
|